A study in mouse models of multiple sclerosis demonstrates a compound called sobetirome promotes remyelination, and a derivative of the compound can penetrate the blood-brain barrier to enable a tenfold increase in infiltration to the CNS. Researchers are confident their research will translate from mice into humans, providing a new avenue of treatment for MS.
from Neuroscience News Updates http://bit.ly/2ZjunW6
from Neuroscience News Updates http://bit.ly/2ZjunW6
Comments
Post a Comment